Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer.
Saved in:
| Title: | Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer. |
|---|---|
| Authors: | Qadri F; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA., Afghan MK; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA., Lutfi A; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA., Javaid S; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA., Guniganti P; Department of Radiology, New York Presbyterian/Weill Cornell Medicine, New York, NY, USA., Cardenes H; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA., Pigazzi A; Department of Surgery, Weill Cornell Medicine, New York, NY, USA., Kasi PM; Oncology and Therapeutics Research, City of Hope Orange County, Irvine, California, 92618, USA. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2026 Mar 19; Vol. 18, pp. 17588359261432049. Date of Electronic Publication: 2026 Mar 19 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41883872 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Qadri+F%22">Qadri F</searchLink>; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Afghan+MK%22">Afghan MK</searchLink>; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lutfi+A%22">Lutfi A</searchLink>; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Javaid+S%22">Javaid S</searchLink>; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Guniganti+P%22">Guniganti P</searchLink>; Department of Radiology, New York Presbyterian/Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cardenes+H%22">Cardenes H</searchLink>; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Pigazzi+A%22">Pigazzi A</searchLink>; Department of Surgery, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kasi+PM%22">Kasi PM</searchLink>; Oncology and Therapeutics Research, City of Hope Orange County, Irvine, California, 92618, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2026 Mar 19; Vol. 18, pp. 17588359261432049. <i>Date of Electronic Publication: </i>2026 Mar 19 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41883872 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/17588359261432049 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 17588359261432049 Titles: – TitleFull: Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Qadri F – PersonEntity: Name: NameFull: Afghan MK – PersonEntity: Name: NameFull: Lutfi A – PersonEntity: Name: NameFull: Javaid S – PersonEntity: Name: NameFull: Guniganti P – PersonEntity: Name: NameFull: Cardenes H – PersonEntity: Name: NameFull: Pigazzi A – PersonEntity: Name: NameFull: Kasi PM IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 03 Text: 2026 Mar 19 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 1758-8340 Numbering: – Type: volume Value: 18 Titles: – TitleFull: Therapeutic advances in medical oncology Type: main |
| ResultId | 1 |
